Clinical Trial

Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR

Name: Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR — clinical trial record (NCT07288190)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate adherence to a single dual-prevention pill (DPP) compared with a two-pill regimen (2PR) for pre-exposure prophylaxis (PrEP) and pregnancy prevention in women without HIV.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-15.

Trial Details

NCT Number	NCT07288190
Lead Sponsor	HIV Prevention Trials Network Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions	Pregnancy, HIV Infections
Enrollment	300 participants
Start Date	2026-05-15
Primary Completion	2028-05-15 (estimated)
Study Completion	2028-05-15 (estimated)
Updated on ClinicalTrials.gov	2026-02-19